埃克洛尼亚 cava 提取物对 DSS 诱导的大肠炎的预防作用,通过提高肠道屏障功能和改善病原性炎症
Young-Mi Kim1, Hye-Youn Kim1, Ji-Tae Jang2
1Lee Gil Ya Cancer and Diabetes Institute, Department of Biochemistry, Gachon University College of Medicine, Incheon 21999, Republic of Korea.
Molecules (Basel, Switzerland)
|December 23, 2023
概括
埃克罗尼亚 cava 提取物 (ECE) 在预防炎症性肠病 (IBD) 中表现有前途. 这种天然化合物通过抑制关键炎症途径并改善肠道健康,减少了小鼠肠炎的严重程度.
科学领域:
- 海洋生物学 海洋生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎和克罗恩病,在死亡率上升的情况下,构成了重大健康挑战.
- 目前的IBD治疗因不可预见的副作用而面临限制,需要探索替代治疗策略.
研究的目的:
- 研究Ecklonia cava提取物 (ECE) 作为IBD的预防剂的潜力.
- 为了评估ECE在硫酸 (DSS) 诱导的大肠炎的小鼠模型中的疗效.
主要方法:
- 在DSS诱导的大肠炎小鼠模型中作为预治疗的ECE的管理.
- 通过结肠长度,脏重量和组织学分析评估结肠炎的严重程度.
- 评估炎症标志物,免疫细胞透,肠道微生物群和NLRP3 / NF-κB信号通路.
主要成果:
- ECE预治疗显著改善了结肠炎的严重程度,改善了结肠的长度和减少了脏的重量.
- ECE减弱了炎症性细胞因子和免疫细胞透的上调.
- ECE缓解了肠道失调,促进了粘膜的愈合,并抑制了NLRP3 / NF-κB通路.
结论:
- 埃克洛尼亚 cava 提取物在IBD预防方面显示出显著的潜力.
- ECE可以作为一种功能性食品成分,促进胃肠道健康.
- 这项研究强调了像ECE这样的天然化合物作为IBD管理的更安全的替代品.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145
Drugs for Treatment of Diarrhea-Predominant IBS
179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179


